ClearNote Health Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

ClearNote Health is a biotechnology company focused on improving early cancer detection through non-invasive blood tests that target epigenomic changes associated with cancer development. It employs a proprietary platform that blends biological data with artificial intelligence to identify DNA-based alterations as cancer evolves. The company has lead programs in non-invasive early detection for pancreatic and ovarian cancers in individuals at the highest risk. Its laboratory operations are CLIA and CAP-accredited and are based in San Diego, California, with additional activity in the San Francisco Bay Area and international reach.

Its work targets patients at high risk for deadly cancers and seeks to enable access to its tests through collaboration with healthcare payors and providers. ClearNote Health positions itself within the oncology and epigenomics landscape as a non-invasive diagnostic option intended to support earlier intervention and potentially improve outcomes. In 2025, the company announced a partnership with Claritev Corporation to make its Avantect diagnostic tests available to Claritev's network of payors and contracted providers.

Sign up for free to view info

Company overview Employee directory